VanEck Biotech ETFNASDAQ:BBH
- LAST PRICE157.91
- TODAY'S CHANGE (%)0.00 (0.00%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 157.91
- Day Range---
- 52 Week Range
- Volume---
- Overall Morningstar Rating2 out of 5 Starsout of 268 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BBH |
|---|---|---|
| 09:32 ET | 510 | 163.49 |
| 09:33 ET | 1300 | 162 |
| 09:48 ET | 200 | 160.28 |
| 09:51 ET | 340 | 159.945 |
| 10:04 ET | 100 | 159.86 |
| 10:09 ET | 300 | 159.33 |
| 10:15 ET | 202 | 158.98 |
| 10:24 ET | 100 | 158.72 |
| 10:54 ET | 205 | 158.0547 |
| 11:07 ET | 100 | 157.78 |
| 11:12 ET | 200 | 157.89 |
| 11:14 ET | 298 | 157.915 |
| 11:18 ET | 187 | 158.05 |
| 11:30 ET | 250 | 158.68 |
| 11:36 ET | 200 | 158.22 |
| 11:52 ET | 113 | 157.8972 |
| 11:54 ET | 100 | 158.1 |
| 12:12 ET | 100 | 158.38 |
| 12:24 ET | 400 | 158.393 |
| 12:35 ET | 350 | 158.12 |
| 12:44 ET | 100 | 158.199 |
| 01:06 ET | 100 | 158.22 |
| 01:36 ET | 100 | 158.2517 |
| 02:18 ET | 100 | 157.75 |
| 03:19 ET | 100 | 157.69 |
| 03:28 ET | 100 | 157.89 |
| 03:42 ET | 300 | 158.09 |
| 03:50 ET | 1900 | 157.82 |
| 03:57 ET | 100 | 157.8 |
| 04:00 ET | 263 | 157.91 |
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 08/20/2024 | -0.10% |
| 08/21/2024 | 0.04% |
| 08/22/2024 | 0.11% |
| 08/23/2024 | -0.03% |
| 08/26/2024 | -0.04% |
| 08/27/2024 | 0.01% |
| 08/28/2024 | 0.10% |
| 08/29/2024 | -0.10% |
| 08/30/2024 | -0.12% |
| 09/03/2024 | 0.09% |
| 09/04/2024 | 0.04% |
| 09/05/2024 Largest Discount | -0.14% |
| 09/06/2024 | 0.11% |
| 09/10/2024 | 0.10% |
| 09/11/2024 | 0.07% |
| 09/12/2024 | 0.10% |
| 09/13/2024 | 0.10% |
| 09/16/2024 | -0.10% |
| 09/17/2024 Largest Premium | 0.12% |
| 09/18/2024 | 0.09% |
| 09/19/2024 | -0.11% |
| 09/20/2024 | 0.09% |
| 09/23/2024 | 0.08% |
| 09/24/2024 | -0.03% |
| 09/25/2024 | -0.02% |
| 09/26/2024 | -0.04% |
| 09/27/2024 | 0.03% |
| 09/30/2024 | -0.06% |
| 10/01/2024 | -0.03% |
| 10/02/2024 Largest Discount | -0.14% |
| 10/03/2024 | 0.06% |
| 10/04/2024 | -0.05% |
| 10/07/2024 | -0.10% |
| 10/08/2024 | 0.10% |
| 10/09/2024 | -0.05% |
| 10/10/2024 | -0.06% |
| 10/11/2024 | -0.12% |
| 10/14/2024 | -0.12% |
| 10/15/2024 | -0.03% |
| 10/16/2024 | -0.02% |
| 10/17/2024 | -0.11% |
| 10/18/2024 | -0.11% |
| 10/21/2024 | 0.03% |
| 10/22/2024 | -0.11% |
| 10/23/2024 | 0.11% |
| 10/24/2024 | -0.10% |
| 10/25/2024 | -0.10% |
| 10/28/2024 | 0.01% |
| 10/29/2024 | 0.09% |
| 10/30/2024 | 0.03% |
| 10/31/2024 | -0.12% |
| 11/01/2024 | -0.12% |
| 11/04/2024 | -0.09% |
| 11/05/2024 | 0.03% |
| 11/06/2024 | -0.12% |
| 11/07/2024 | -0.02% |
| 11/08/2024 | 0.00% |
| 11/11/2024 | -0.12% |
| 11/12/2024 | 0.08% |
| 11/13/2024 | 0.11% |
| 11/14/2024 | -0.04% |
| 11/15/2024 | 0.10% |
| US Stock | 95.7% |
|---|---|
| Non-US Stock | 4.2% |
| Cash | 0.1% |
| Convertible | 0 |
| Non-US Bond | 0 |
| Other | 0 |
| Healthcare | 99.9% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 95.8% |
|---|---|
| Europe | 2.4% |
| Latin America | 0 |
| Africa | 0 |
| Canada | 0 |
| Asia/Oceania | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Amgen Inc | Long | 16.9% | -0.98% | $73.5M |
Vertex Pharmaceuticals Inc | Long | 10.5% | -0.98% | $45.4M |
Gilead Sciences Inc | Long | 9.9% | -0.98% | $43.2M |
Regeneron Pharmaceuticals Inc | Long | 7.7% | -0.98% | $33.7M |
argenx SE ADR | Long | 4.8% | -0.98% | $20.9M |
IQVIA Holdings Inc | Long | 4.7% | -0.98% | $20.6M |
Illumina Inc | Long | 4.3% | -0.98% | $18.6M |
Biogen Inc | Long | 4.1% | -0.98% | $17.7M |
Icon PLC | Long | 3.7% | -0.98% | $15.9M |
Alnylam Pharmaceuticals Inc | Long | 3.6% | -0.98% | $15.7M |
Reports
- ManagedInvestmentETF11/10/24
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
- EtfValuationReport03/28/13
Morningstar ETF Report
The Morningstar ETF Report offers in-depth analyst research on exchange-traded funds to help you evaluate these investments and how they fit within a portfolio.
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | 2 out of 5 Stars |
| 3 Year Rating | 2 out of 5 Stars |
| 5 Year Rating | 2 out of 5 Stars |
| 10 Year Rating | 2 out of 5 Stars |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | MVIS US Listed Biotech 25 NR USD |
|---|---|
Category | |
Sponsor | Van Eck Associates Corporation |
Inception | December 20, 2011 |
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
| Total Net Assets | $428.3M |
|---|---|
| Shares Out. | 2.5M |
| Net Asset Value (NAV) | $157.75 |
| Prem/Discount to NAV | 0.10% |
| P/E Ratio | 32.5 |
| Dividend Yield | 0.45% |
| Dividend per Share | 0.71 USD |
| Ex-Dividend Date | 12/18/2023 |
| Dividend Payment Date | 12/22/2023 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Mid Cap Blend |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.35% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | 0.35% |